BioMarin’s Voxzogo Predicted For Blockbuster Sales, But Market Must Be Built
Executive Summary
Very early launch numbers look good in France and Germany, but US launch will be more challenging due to a fragmented patient base, the company said. Launch price is a flat $899 per vial.